3d Military Medical University develop „superbug vaccine“, active against S. aureus

The team aroud ZOU Quanming is now entering clinical trials with patients 18 – 59 years old to bring this recombinant vaccine to the market, in view of reducing the risks of MRSA infections of compromised patients.

China Bio news release, August 6, 2015

Most popular posts: